i n f l a r x

Loading

Impressum Privacy policy

Contact us

+49 3641 508 180

info@inflarx.de

Address

InflaRx N.V.

Winzerlaer Str. 2, 07745 Jena

Press Release
Home Investors Press Releases Press Release

InflaRx Provides Update on Development Plans for Vilobelimab in Hidradenitis Suppurativa

Feb 28, 2022

Time to read 4 Minutes
  Download PDF


Back